Kim Stebbings

January 8, 2021

Kim has 35+ years of U.S. medical device sales, marketing and operational experience in multi-national and start-up companies. She spent 16 years with Boehringer Mannheim/Roche where she held multiple positions in sales/ marketing including P&L responsibility for a $100 million diabetes care diagnostics business. The balance of her career has been dedicated to leading start-up medical device organizations with game-changing technologies including BioStar, a diagnostics company sold to Thermo Electron (NYSE:TMO), Medingo, an Israeli insulin patch pump company acquired by Roche (ROG.VX), Anodyne Therapy, a pain management company and GlycoMark, a start-up subsidiary of Toyota. Kim retired in May 2017 as U.S. President of DYSIS Medical, Inc., where she built the U.S. business to a team of 20 with revenues exceeding $1.2 MM in the first year. She was also integrally involved in managing a 7500 patient study, and the study publications and reimbursement strategy. Under her guidance, her team built a national network of DYSIS Cervical Centers of Excellence offering this transformational imaging system that improves accuracy in detecting pre-cancers in women with abnormal Pap smears.

Kim was Director of Mentoring for the Healthcare Businesswomen’s Association, a member of Vistage, and in 2015, earned recognition as the Tampa Bay Businesswoman of the Year in the Health and Wellness category. She currently consults with DYSIS and mentors a number of entrepreneurs at the Florida-Israeli Business Accelerator (www.fiba.io), and University of Tampa’s Entrepreneurship Program.